Non classé
17 September 2020
SPPS 600L reactor

PolyPeptide News Flash, #3, 2020

As a Global Leader in Peptide Manufacturing and Development, the PolyPeptide Group has been actively engaged on projects with clients who are developing peptide-based therapies and […]
4 June 2020

Press Release: PolyPeptide Group Selected by Novavax to Manufacture Critical Intermediates of Matrix-M™ Adjuvant for its COVID-19 Vaccine

The PolyPeptide Group, a global Contract Development and Manufacturing Organization (CDMO) for Peptide, Peptidomimetic and other Drug Substances, has announced that it has partnered with Novavax […]
12 May 2020

PolyPeptide News Flash, #2, 2020

While the COVID-19 crisis continues, the PolyPeptide Group is actively engaged in helping find treatments and vaccines for COVID-19. See report on promising therapies in our […]
23 April 2020

Information Letter on COVID-19

Download letter PDF here   Dear Valued Customer, While the COVID-19 crisis continues, I want to assure you that the PolyPeptide Group remains ready to support […]
26 March 2020

Information Letter on COVID-19

Download letter PDF here  
24 February 2020
MVA Medicona Valley Alliance

New member of the Medicon Valley Alliance

We are happy to inform that the PolyPeptide Group is from now a member of the Medicon Valley Alliance (MVA). It is a non-profit membership organization, […]
12 February 2020

PolyPeptide News Flash February 2020

  In 2019 we made significant progress in reducing solvent consumption. Our goal is to become the greenest solution provider for peptides, learn more in our […]
9 January 2020
Innovation & Technology

Innovation and Technology

Innovation is considered as a key driver for the future of our business. In 2020 we will highlight our focus and progress on Innovation and Technology […]
24 October 2019

PolyPeptide News Flash October

Find out the latest news in our October Newsletter